CLINICAL_TRIALS
trial_result
· 2021-05-05
Clinical Trial Update: Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes [Phase 4]
Summary
Phase 4 trial assessing the effect of neprilysin on GLP-1 in patients with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Copenhagen | Conditions: Type2 Diabetes | Phase 4 | Status: COMPLETED